Redmile Group, LLC
CIK 1425738 · last filed 2026-07-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$164.09M
Companies
17
Total Filings
33
Lifetime Open-Market Net
$152.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATRA | Director | 636,852 | $7.81 | $4.97M | $0 | 1 | 2026-07-24 |
| ADCT | 10%+ Owner | 25,735,799 | $1.11 | $28.57M | -$58.91M | 2 | 2026-04-02 |
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 2,964,843 | $1.27 | $3.77M | $14.63M | 4 | 2025-07-02 |
| STTK | Director | 5,539,724 | $6.82 | $37.78M | $0 | 1 | 2024-12-06 |
| Augmedix, Inc. (AUGX) Delisted | Director | 25,850,163 | $2.35 | $60.75M | $37.50M | 2 | 2023-11-22 |
| ABSI | Director | — | $7.13 | — | $0 | 1 | 2022-06-10 |
| TRDA | 10%+ Owner | 954,420 | $5.83 | $5.56M | $60.00M | 1 | 2021-11-04 |
| Science 37 Holdings, Inc. (SNCE) Delisted | Director | 987,539 | $5.75 | $5.68M | $0 | 1 | 2021-10-08 |
| FATE | Director | 12,957,222 | $2.32 | $30.06M | $56.00M | 1 | 2021-01-12 |
| NRIX | 10%+ Owner | 1,176,470 | $24.15 | $28.41M | $0 | 1 | 2020-07-30 |
| PLRX | 10%+ Owner | 1,910,657 | $1.07 | $2.04M | $0 | 1 | 2020-06-09 |
| CABA | 10%+ Owner | 696,378 | $2.73 | $1.90M | $0 | 1 | 2019-10-29 |
| APRE | 10%+ Owner | 93,436 | $0.61 | $57.3K | $12.00M | 1 | 2019-10-08 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | — | — | — | $0 | 4 | 2019-07-01 |
| HOOKIPA Pharma Inc. (HOOK) Delisted | 10%+ Owner | 99,932 | $1.15 | $114.9K | $0 | 1 | 2019-04-24 |
| XERS | 10%+ Owner | 3,000,642 | $8.24 | $24.73M | $31.76M | 2 | 2019-02-21 |
| Gritstone bio, Inc. (GRTS) Delisted | 10%+ Owner | 869,562 | $0.03 | $28.0K | $0 | 1 | 2018-10-03 |
Recent Filings · Page 2 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | ABSI | Grant (A) | — | $0 | EDGAR |
| 2021-11-04 | TRDA | Mixed | +5,863,260 | $60.00M | EDGAR |
| 2021-10-08 | Science 37 Holdings, Inc. (SNCE) Delisted | Grant (A) | +29,501,572 | $0 | EDGAR |
| 2021-01-12 | FATE | Buy (P) | +654,970 | $56.00M | EDGAR |
| 2020-10-07 | — | Buy (P) | +10,000,000 | $30.00M | |
| 2020-09-09 | IGM Biosciences, Inc. (IGMS) Delisted | Buy (P) | +289,612 | $14.63M | EDGAR |
| 2020-07-30 | NRIX | Conv (C) | +2,352,940 | $0 | EDGAR |
| 2020-06-09 | PLRX | Conv (C) | +3,821,314 | $0 | EDGAR |
| 2019-10-29 | CABA | Conv (C) | +1,392,756 | $0 | EDGAR |
| 2019-10-08 | APRE | Mixed | +4,537,436 | $12.00M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.